LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 319

Search options

  1. Article ; Online: Identify MicroRNA Targets Using AGO2-CLASH (Cross-linking, Ligation, and Sequencing of Hybrids) and AGO2-CLIP (Cross-Linking and Immuno-Precipitation) in Cells with or Without the MicroRNA of Interest Depleted.

    Kato, Mitsuo

    Methods in molecular biology (Clifton, N.J.)

    2023  Volume 2666, Page(s) 137–147

    Abstract: MicroRNAs (miRNAs) are short noncoding RNAs and important players in the regulation of gene expression through post-transcriptional mechanisms. MicroRNAs regulate many cellular processes and are involved in disease progression. Identification of novel ... ...

    Abstract MicroRNAs (miRNAs) are short noncoding RNAs and important players in the regulation of gene expression through post-transcriptional mechanisms. MicroRNAs regulate many cellular processes and are involved in disease progression. Identification of novel miRNA-to-target RNA connections can fill the gaps in the signaling pathways and suggest new therapeutic targets. MiRNA targets are often predicted by base-complementarity of their seed and flanking sequences with target sequences. Direct targets can also be identified by the physical interaction between the miRNA and the target RNA using immunoprecipitation of the Argonaute (AGO) protein, a component of the RNA-induced silencing complex, followed by ligation of AGO-associated miRNA and target RNA and next generation sequencing (CLASH). Databases describing these miRNA-RNA interactions have been generated from cells commonly studied or used. However, because the regulation by miRNAs varies among organs, tissues, cell types and species, identifying relevant targets in specific cells under conditions of interest may not be available. Here, the author describes simplified methods of AGO2-CLASH and AGO2-CLIP to identify miRNA targets by comparing primary cells derived from wild-type mice and those from specific miRNA knockout mice.
    MeSH term(s) Animals ; Mice ; MicroRNAs/genetics ; MicroRNAs/metabolism ; RNA-Induced Silencing Complex/metabolism ; Cell Line ; Argonaute Proteins/genetics ; Argonaute Proteins/metabolism ; Immunoprecipitation
    Chemical Substances MicroRNAs ; RNA-Induced Silencing Complex ; Argonaute Proteins
    Language English
    Publishing date 2023-05-11
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1940-6029
    ISSN (online) 1940-6029
    DOI 10.1007/978-1-0716-3191-1_10
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Intercellular transmission of endoplasmic reticulum stress through gap junction targeted by microRNAs as a key step of diabetic kidney diseases?

    Kato, Mitsuo

    Annals of translational medicine

    2021  Volume 9, Issue 10, Page(s) 827

    Language English
    Publishing date 2021-06-20
    Publishing country China
    Document type Editorial
    ZDB-ID 2893931-1
    ISSN 2305-5847 ; 2305-5839
    ISSN (online) 2305-5847
    ISSN 2305-5839
    DOI 10.21037/atm-21-1280
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Target RNA-directed microRNA degradation; which controls which?

    Kato, Mitsuo

    Non-coding RNA investigation

    2018  Volume 2

    Language English
    Publishing date 2018-11-14
    Publishing country China
    Document type Journal Article ; Comment
    ISSN 2522-6673
    ISSN (online) 2522-6673
    DOI 10.21037/ncri.2018.11.01
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Noncoding RNAs as therapeutic targets in early stage diabetic kidney disease.

    Kato, Mitsuo

    Kidney research and clinical practice

    2018  Volume 37, Issue 3, Page(s) 197–209

    Abstract: Diabetic kidney disease (DKD) is a major renal complication of diabetes that leads to renal dysfunction and end-stage renal disease (ESRD). Major features of DKD include accumulation of extracellular matrix proteins and glomerular hypertrophy, especially ...

    Abstract Diabetic kidney disease (DKD) is a major renal complication of diabetes that leads to renal dysfunction and end-stage renal disease (ESRD). Major features of DKD include accumulation of extracellular matrix proteins and glomerular hypertrophy, especially in early stage. Transforming growth factor-β plays key roles in regulation of profibrotic genes and signal transducers such as Akt kinase and MAPK as well as endoplasmic reticulum stress, oxidant stress, and autophagy related to hypertrophy in diabetes. Many drugs targeting the pathogenic signaling in DKD (mostly through protein-coding genes) are under development. However, because of the limited number of protein-coding genes, noncoding RNAs (ncRNAs) including microRNAs (miRNAs) and long noncoding RNAs (lncRNAs) are attracting more attention as potential new drug targets for human diseases. Some miRNAs and lncRNAs regulate each other (by hosting, enhancing transcription from the neighbor, hybridizing each other, and changing chromatin modifications) and create circuits and cascades enhancing the pathogenic signaling in DKD. In this short and focused review, the functional significance of ncRNAs (miRNAs and lncRNAs) in the early stages of DKD and their therapeutic potential are discussed.
    Language English
    Publishing date 2018-09-30
    Publishing country Korea (South)
    Document type Journal Article ; Review
    ZDB-ID 2656420-8
    ISSN 2211-9132
    ISSN 2211-9132
    DOI 10.23876/j.krcp.2018.37.3.197
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Noncoding RNAs as therapeutic targets in early stage diabetic kidney disease

    Mitsuo Kato

    Kidney Research and Clinical Practice, Vol 37, Iss 3, Pp 197-

    2018  Volume 209

    Abstract: Diabetic kidney disease (DKD) is a major renal complication of diabetes that leads to renal dysfunction and end-stage renal disease (ESRD). Major features of DKD include accumulation of extracellular matrix proteins and glomerular hypertrophy, especially ...

    Abstract Diabetic kidney disease (DKD) is a major renal complication of diabetes that leads to renal dysfunction and end-stage renal disease (ESRD). Major features of DKD include accumulation of extracellular matrix proteins and glomerular hypertrophy, especially in early stage. Transforming growth factor-β plays key roles in regulation of profibrotic genes and signal transducers such as Akt kinase and MAPK as well as endoplasmic reticulum stress, oxidant stress, and autophagy related to hypertrophy in diabetes. Many drugs targeting the pathogenic signaling in DKD (mostly through protein-coding genes) are under development. However, because of the limited number of protein-coding genes, noncoding RNAs (ncRNAs) including microRNAs (miRNAs) and long noncoding RNAs (lncRNAs) are attracting more attention as potential new drug targets for human diseases. Some miRNAs and lncRNAs regulate each other (by hosting, enhancing transcription from the neighbor, hybridizing each other, and changing chromatin modifications) and create circuits and cascades enhancing the pathogenic signaling in DKD. In this short and focused review, the functional significance of ncRNAs (miRNAs and lncRNAs) in the early stages of DKD and their therapeutic potential are discussed.
    Keywords Diabetic nephropathies ; Long noncoding RNA ; MicroRNAs ; Signal transduction ; Untranslated RNA ; Internal medicine ; RC31-1245 ; Specialties of internal medicine ; RC581-951
    Language English
    Publishing date 2018-09-01T00:00:00Z
    Publisher The Korean Society of Nephrology
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: A phase 2, open-label study of ibrutinib plus rituximab in Japanese patients with Waldenstrom's macroglobulinemia.

    Izutsu, Koji / Kato, Hisashi / Sekiguchi, Naohiro / Fujisaki, Tomoaki / Kawakita, Toshiro / Obara, Naoshi / Matsue, Kosei / Nishimoto, Mitsutaka / Hatayama, Tomoyoshi / Inagaki, Mitsuo / Fujikawa, Ei

    International journal of hematology

    2024  

    Abstract: Ibrutinib is a first-in-class Bruton kinase inhibitor against B-cell neoplasms including Waldenström macroglobulinemia (WM). This study evaluated the efficacy and safety of ibrutinib-rituximab in Japanese patients with WM. Patients received ibrutinib 420  ...

    Abstract Ibrutinib is a first-in-class Bruton kinase inhibitor against B-cell neoplasms including Waldenström macroglobulinemia (WM). This study evaluated the efficacy and safety of ibrutinib-rituximab in Japanese patients with WM. Patients received ibrutinib 420 mg orally once daily plus weekly rituximab 375 mg/m
    Language English
    Publishing date 2024-04-10
    Publishing country Japan
    Document type Journal Article
    ZDB-ID 1076875-0
    ISSN 1865-3774 ; 0917-1258 ; 0925-5710
    ISSN (online) 1865-3774
    ISSN 0917-1258 ; 0925-5710
    DOI 10.1007/s12185-024-03761-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Epigenetics and epigenomics in diabetic kidney disease and metabolic memory.

    Kato, Mitsuo / Natarajan, Rama

    Nature reviews. Nephrology

    2019  Volume 15, Issue 6, Page(s) 327–345

    Abstract: The development and progression of diabetic kidney disease (DKD), a highly prevalent complication of diabetes mellitus, are influenced by both genetic and environmental factors. DKD is an important contributor to the morbidity of patients with diabetes ... ...

    Abstract The development and progression of diabetic kidney disease (DKD), a highly prevalent complication of diabetes mellitus, are influenced by both genetic and environmental factors. DKD is an important contributor to the morbidity of patients with diabetes mellitus, indicating a clear need for an improved understanding of disease aetiology to inform the development of more efficacious treatments. DKD is characterized by an accumulation of extracellular matrix, hypertrophy and fibrosis in kidney glomerular and tubular cells. Increasing evidence shows that genes associated with these features of DKD are regulated not only by classical signalling pathways but also by epigenetic mechanisms involving chromatin histone modifications, DNA methylation and non-coding RNAs. These mechanisms can respond to changes in the environment and, importantly, might mediate the persistent long-term expression of DKD-related genes and phenotypes induced by prior glycaemic exposure despite subsequent glycaemic control, a phenomenon called metabolic memory. Detection of epigenetic events during the early stages of DKD could be valuable for timely diagnosis and prompt treatment to prevent progression to end-stage renal disease. Identification of epigenetic signatures of DKD via epigenome-wide association studies might also inform precision medicine approaches. Here, we highlight the emerging role of epigenetics and epigenomics in DKD and the translational potential of candidate epigenetic factors and non-coding RNAs as biomarkers and drug targets for DKD.
    MeSH term(s) Blood Glucose/metabolism ; DNA Methylation/genetics ; Diabetes Mellitus/drug therapy ; Diabetes Mellitus/metabolism ; Diabetic Nephropathies/drug therapy ; Diabetic Nephropathies/genetics ; Diabetic Nephropathies/metabolism ; Disease Progression ; Epigenesis, Genetic/genetics ; Epigenomics ; Gene-Environment Interaction ; Histone Code/genetics ; Humans ; Hypoglycemic Agents/therapeutic use ; Kidney Failure, Chronic/genetics ; Kidney Failure, Chronic/metabolism ; Molecular Targeted Therapy ; Precision Medicine ; RNA, Untranslated/genetics ; Renal Insufficiency, Chronic/drug therapy ; Renal Insufficiency, Chronic/genetics ; Renal Insufficiency, Chronic/metabolism
    Chemical Substances Blood Glucose ; Hypoglycemic Agents ; RNA, Untranslated
    Language English
    Publishing date 2019-03-21
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2490366-8
    ISSN 1759-507X ; 1759-5061
    ISSN (online) 1759-507X
    ISSN 1759-5061
    DOI 10.1038/s41581-019-0135-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: TGF-β-induced signaling circuit loops mediated by microRNAs as new therapeutic targets for renal fibrosis?

    Kato, Mitsuo

    Kidney international

    2013  Volume 84, Issue 6, Page(s) 1067–1069

    Abstract: MicroRNAs (miRNAs) are emerging molecules in the pathogenesis of human diseases. Identification of miRNAs related to renal fibrosis provides clues to find new signaling pathways to fill the gaps between signaling molecules. Li et al. report another new ... ...

    Abstract MicroRNAs (miRNAs) are emerging molecules in the pathogenesis of human diseases. Identification of miRNAs related to renal fibrosis provides clues to find new signaling pathways to fill the gaps between signaling molecules. Li et al. report another new pathway mediated by miR-433 that is induced by transforming growth factor-β1 in mouse models of renal fibrosis. The signaling also makes a positive-feedback circuit loop, which could be translated into new therapeutic targets.
    MeSH term(s) Animals ; Carrier Proteins/metabolism ; Kidney/metabolism ; Kidney Diseases/metabolism ; Male ; MicroRNAs/metabolism ; Smad3 Protein/metabolism ; Transforming Growth Factor beta1/metabolism
    Chemical Substances Carrier Proteins ; MicroRNAs ; Mirn433 microRNA, mouse ; Smad3 Protein ; Smad3 protein, mouse ; Tgfb1 protein, mouse ; Transforming Growth Factor beta1 ; ornithine decarboxylase antizyme inhibitor
    Language English
    Publishing date 2013-12
    Publishing country United States
    Document type Comment ; Journal Article
    ZDB-ID 120573-0
    ISSN 1523-1755 ; 0085-2538
    ISSN (online) 1523-1755
    ISSN 0085-2538
    DOI 10.1038/ki.2013.297
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Long non-coding RNA lncMGC mediates the expression of TGF-β-induced genes in renal cells via nucleosome remodelers.

    Kato, Mitsuo / Chen, Zhuo / Das, Sadhan / Wu, Xiwei / Wang, Jinhui / Li, Arthur / Chen, Wei / Tsark, Walter / Tunduguru, Ragadeepthi / Lanting, Linda / Wang, Mei / Moore, Roger / Kalkum, Markus / Abdollahi, Maryam / Natarajan, Rama

    Frontiers in molecular biosciences

    2023  Volume 10, Page(s) 1204124

    Abstract: Background: ...

    Abstract Background:
    Language English
    Publishing date 2023-05-30
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2814330-9
    ISSN 2296-889X
    ISSN 2296-889X
    DOI 10.3389/fmolb.2023.1204124
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Characterizing user demographics in posts related to breast, lung and colon cancer on Japanese twitter (X).

    Kusudo, Maho / Terada, Mitsuo / Kureyama, Nari / Wanifuchi-Endo, Yumi / Fujita, Takashi / Asano, Tomoko / Kato, Akiko / Mori, Makiko / Horisawa, Nanae / Toyama, Tatsuya

    Scientific reports

    2024  Volume 14, Issue 1, Page(s) 6485

    Abstract: Various cancer-related information is spreading on social media. Our study aimed to examine the account types associated with cancer-related tweets (currently known as posts) on Twitter (currently known as X) in Japan, specifically focusing on breast, ... ...

    Abstract Various cancer-related information is spreading on social media. Our study aimed to examine the account types associated with cancer-related tweets (currently known as posts) on Twitter (currently known as X) in Japan, specifically focusing on breast, lung, and colon cancer. Using the Twitter application programming interface, we collected tweets containing keywords of the three cancers type in August-September 2022. The accounts were categorized into seven types: Survivor, Patient's family, Healthcare provider, Public organization, Private organization, News, and Other according to account name and texts. We analyzed the sources of the top 50 most liked and retweeted tweets. Out of 7753 identified tweets, breast cancer represented the majority (62.8%), followed by lung cancer (20.8%) and colon cancer (16.3%). Tweets came from 4976 accounts. Account types varied depending on the cancer type, with breast cancer topics more frequently from Survivor (16.0%) and lung cancer from Patient's family (16.3%). Healthcare provider and Public organization had minimal representation across three cancer types. The trends in the top 50 tweets mirrored the distribution of accounts for each cancer type. Breast cancer-related tweets had the highest frequency. There were few from public organizations. These findings emphasize the need to consider the characteristics of cancer-related information sources when sharing and gathering information on social media.
    MeSH term(s) Humans ; Female ; Social Media ; Japan/epidemiology ; Colonic Neoplasms/epidemiology ; Breast Neoplasms/epidemiology ; Lung Neoplasms/epidemiology ; Lung ; Demography
    Language English
    Publishing date 2024-03-18
    Publishing country England
    Document type Journal Article
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-024-56679-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top